Pulmonary fibrosis in COVID‐19 survivors: Predictive factors and risk reduction strategies
Although pulmonary fibrosis can occur in the absence of a clear‐cut inciting agent, and
without a clinically clear initial acute inflammatory phase, it is more commonly associated …
without a clinically clear initial acute inflammatory phase, it is more commonly associated …
Genetics insight for COVID-19 susceptibility and severity: a review
Coronavirus disease (COVID-19) presents a broad spectrum of clinical manifestations
ranging from an asymptomatic to a severe clinical course. The host genetic background …
ranging from an asymptomatic to a severe clinical course. The host genetic background …
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
X Wu, X Liu, Y Zhou, H Yu, R Li, Q Zhan… - The Lancet …, 2021 - thelancet.com
Background The consequences of COVID-19 in those who recover from acute infection
requiring hospitalisation have yet to be clearly defined. We aimed to describe the temporal …
requiring hospitalisation have yet to be clearly defined. We aimed to describe the temporal …
[HTML][HTML] European Respiratory Society statement on long COVID follow-up
Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …
[HTML][HTML] The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients
AG Fois, P Paliogiannis, V Scano, S Cau, S Babudieri… - Molecules, 2020 - mdpi.com
Background. The rapid onset of a systemic pro-inflammatory state followed by acute
respiratory distress syndrome is the leading cause of mortality in patients with COVID-19 …
respiratory distress syndrome is the leading cause of mortality in patients with COVID-19 …
Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
K Cares-Marambio… - Chronic respiratory …, 2021 - journals.sagepub.com
Knowledge on the sequelae of Coronavirus Disease 2019 (COVID-19) remains limited due
to the relatively recent onset of this pathology. However, the literature on other types of …
to the relatively recent onset of this pathology. However, the literature on other types of …
First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics
S Saito, Y Asai, N Matsunaga… - The Journal of …, 2020 - pmc.ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, becomes
clinically manifest in a broad range from mild symptoms to life-threatening multi-organ failure …
clinically manifest in a broad range from mild symptoms to life-threatening multi-organ failure …
Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis
Background Understanding the factors associated with disease severity and mortality in
Coronavirus disease (COVID-19) is imperative to effectively triage patients. We performed a …
Coronavirus disease (COVID-19) is imperative to effectively triage patients. We performed a …
Clinical features and outcomes of HIV patients with coronavirus disease 2019
C Gervasoni, P Meraviglia, A Riva… - … diseases: an official …, 2020 - pmc.ncbi.nlm.nih.gov
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. All rights reserved. For …
University Press for the Infectious Diseases Society of America. All rights reserved. For …
Post covid 19 pulmonary fibrosis. Is it real threat?
After the COVID-19 outbreak, increasing number of patients worldwide who have survived
COVID-19 continue to battle the symptoms of the illness, long after they have been clinically …
COVID-19 continue to battle the symptoms of the illness, long after they have been clinically …